Donor lymphocyte infusions: An experience from a tertiary care center of North India
Donor lymphocyte infusions (DLIs) are often recommended products after allogeneic hematopoietic stem cell transplant to increase graft – versus – leukemia effect. More success rate of DLI has been reported in relapsed posttransplant chronic myeloid leukemia. Whatever the indication for DLI, mortalit...
Saved in:
Main Authors: | Divjot Singh Lamba, Parmatma Prasad Tripathi, Rekha Hans, Alka Khadwal, Ratti Ram Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Asian Journal of Transfusion Science |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ajts.ajts_211_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience
by: Yusuke Uchibori, et al.
Published: (2025-01-01) -
New T-lymphocyte subpopulations and their characteristics: Challenges to the classical division of lymphocyte function
by: Filip Lewandowski, et al.
Published: (2024-11-01) -
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
by: Jongbok Lee, et al.
Published: (2025-01-01) -
Tumor-Infiltrating Lymphocytes and Neutrophils and Their Location in Canine Mammary Neoplasms with a Solid Arrangement: A Prognostic Factor?
by: Mayra C. Flecher, et al.
Published: (2025-01-01) -
Satisfaction and Preferences for Infusion Therapies in Advanced Parkinson’s Disease—Patient Perspective
by: Julia Węgrzynek-Gallina, et al.
Published: (2024-12-01)